What is the target hemoglobin (Hgb) level in pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Target Hemoglobin Levels in Pregnancy

The target hemoglobin level in pregnancy should be ≥11 g/dL in the first trimester and ≥10.5 g/dL in the second and third trimesters. 1

Normal Hemoglobin Changes During Pregnancy

  • Pregnancy causes physiological changes in hemoglobin concentration due to increased plasma volume and hemodilution 2
  • In iron-replete women, the 5th percentile for hemoglobin is approximately:
    • 110 g/L (11 g/dL) in the first trimester
    • 105 g/L (10.5 g/dL) in the second and third trimesters 3
  • These values represent the lower limit of normal in women receiving adequate iron supplementation 3

Defining Anemia in Pregnancy

  • Anemia is defined as hemoglobin <11 g/dL in the first trimester and <10.5 g/dL in the second and third trimesters 1
  • Iron deficiency is the most common cause (approximately 75%) of anemia in pregnancy 2
  • Screening is recommended with a complete blood count in the first trimester and again at 24-28 weeks gestation 1

Clinical Implications of Different Hemoglobin Levels

  • Mild anemia (Hb 10.0-10.9 g/dL):

    • Generally well-tolerated with minimal adverse outcomes 4
    • May actually be associated with decreased risks of certain complications compared to no anemia 4
    • Should be treated with oral iron supplementation 1
  • Moderate anemia (Hb 7.0-9.9 g/dL):

    • Associated with increased risks of placental abruption (aOR 1.98), preterm birth (aOR 1.18), and severe postpartum hemorrhage (aOR 3.53) 4
    • Requires further investigation beyond simple iron deficiency 1
  • Severe anemia (Hb <7.0 g/dL):

    • Associated with significantly higher risks of maternal and fetal complications 4
    • Linked to increased risk of maternal shock (aOR 14.98), ICU admission (aOR 2.88), and stillbirth (aOR 1.86) 4
    • Hemoglobin levels <6 g/dL correlate with poor pregnancy outcomes including prematurity, spontaneous abortions, low birth weight, and fetal deaths 2

Special Considerations

For Sickle Cell Disease

  • For pregnant women with sickle cell disease, target hemoglobin should be >7.0 g/dL 5
  • If transfusions are needed, aim for HbS level of <50% 5

For Congenital Fibrinogen Disorders

  • In women with afibrinogenemia and hypofibrinogenemia:
    • Target fibrinogen level of ≥1 g/L throughout pregnancy 5
    • Increase to ≥1.5 g/L in case of vaginal bleeding or during labor and delivery 5

For Diabetes in Pregnancy

  • No specific hemoglobin targets different from non-diabetic pregnant women 5
  • Focus on glycemic targets:
    • Fasting glucose <95 mg/dL
    • One-hour postprandial glucose <140 mg/dL
    • Two-hour postprandial glucose <120 mg/dL 5

Treatment Approach for Anemia in Pregnancy

  • First-line treatment for iron deficiency anemia is oral iron supplementation 1
  • For patients who cannot tolerate, absorb, or respond to oral iron, intravenous iron is preferred 1
  • Monitoring hemoglobin levels throughout pregnancy is essential to ensure targets are maintained 3

Clinical Pitfalls to Avoid

  • Do not confuse physiologic hemodilution of pregnancy with true anemia requiring treatment 6
  • Values outside the normal range are associated with pregnancy complications and fetal growth restriction 6
  • Avoid overdiagnosis of anemia by using trimester-specific cutoffs rather than non-pregnant reference ranges 3
  • Recognize that mild anemia may not require aggressive intervention, while moderate to severe anemia demands prompt evaluation and treatment 4

References

Research

Iron Deficiency Anemia in Pregnancy.

Obstetrics and gynecology, 2021

Research

Anemia in pregnancy.

Annals of the New York Academy of Sciences, 2000

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[The critical hemoglobin/hematocrit value in obstetrics].

Beitrage zur Infusionstherapie = Contributions to infusion therapy, 1992

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.